Skip to main content
Erschienen in: Kidney 6/2010

01.12.2010

Serum Lipid Profile and Plasma Fatty Acids Levels in Hemodialysis Pediatric Patients-Possible Deficiency of Essential Fatty Acids

verfasst von: Manal Fuad Elshamaa, Samar Mohamed Sabry, Eman Ahmed Elghoroury, Gamila Soliman El-Saaid, Dina Kandil

Erschienen in: Kidney | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Polyunsaturated fatty acids (PUFA) are reported to be associated with atherosclerotic and inflammatory diseases because they are the major components of the cytoplasmic membrane and are the precursor fatty acids for prostaglandins and leukotrienes. Aim of this study was to identify PUFA profile (PUFAp) in children with end stage renal disease (ESRD) on hemodialysis (HD). And study its relationship with known cardiovascular and arteriosclerotic risk factors. We examined 44 pediatric HD patients (mean age 11 ± 3.36 years). Plasma lipid profile, plasma fatty acid pattern, serum albumin and hemoglobin were studied in these children. Triglyceride levels were increased in the plasma of ESRD patients compared to the healthy subjects. Plasma PUFA decreased whereas behanic acid (saturated fatty acid) increased in ESRD patients. A lower level of eicosapentaenoic acid was revealed in HD patients with cardiomyopathy (HD-CAD) than those without cardiovascular disease(HD-norm) (0.20 ± 0.01 μ/mL vs. 0.88 ± 0.12 μ/mL, P = 0.01). An inverse correlation was found between the linoleic acid level and serum TG level in children on HD (r = −0.54, P = 0.03). A positive correlation was found between plasma arachidonic acid level and serum albumin (r = 0.86, P = 0.003). A significant positive correlation was revealed between plasma eicosapentaenoic acid concentration and serum hemoglobin level (r = −0.64, P = 0.04). Saturated acid was negatively correlated with serum albumin (r = −0.70, P = 0.03). Children under regular hemodialysis evidence significant abnormalities in serum fatty acid levels together with triglyceride abnormalities, a finding that might be relevant to the risk of cardiovascular disease in this setting.
Literatur
1.
Zurück zum Zitat Stenvinkel P. Inflammatory and atherosclerosis interactions in the depleted uremic patients. Blood Purif. 2001;19:53–61.CrossRefPubMed Stenvinkel P. Inflammatory and atherosclerosis interactions in the depleted uremic patients. Blood Purif. 2001;19:53–61.CrossRefPubMed
2.
3.
Zurück zum Zitat Hahn R, Oette K, Mondorf H, Finke K, Sieberth HG. Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis. 1983;48:279–88.CrossRefPubMed Hahn R, Oette K, Mondorf H, Finke K, Sieberth HG. Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis. 1983;48:279–88.CrossRefPubMed
4.
Zurück zum Zitat Saland JM, Ginsberg HN. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol. 2007;22:1095–112.CrossRefPubMed Saland JM, Ginsberg HN. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol. 2007;22:1095–112.CrossRefPubMed
5.
Zurück zum Zitat Sinclair HM. Essential fatty acids—an historical perspective. Biochem Soc Trans. 1990;18:756–61.PubMed Sinclair HM. Essential fatty acids—an historical perspective. Biochem Soc Trans. 1990;18:756–61.PubMed
6.
Zurück zum Zitat Stubbs CD, Smith AD. Essential fatty acids in membrane: physical properties and function. Biochem Soc Trans. 1990;18:779–81.PubMed Stubbs CD, Smith AD. Essential fatty acids in membrane: physical properties and function. Biochem Soc Trans. 1990;18:779–81.PubMed
7.
Zurück zum Zitat Koorts AM, Viljoen M, Kruger MC. Red blood cell fatty acid profile in chronic renal failure patients receiving maintenance hemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids. 2002;67:13–8.CrossRefPubMed Koorts AM, Viljoen M, Kruger MC. Red blood cell fatty acid profile in chronic renal failure patients receiving maintenance hemodialysis treatment. Prostaglandins Leukot Essent Fatty Acids. 2002;67:13–8.CrossRefPubMed
8.
Zurück zum Zitat Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–911.CrossRefPubMed Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–911.CrossRefPubMed
10.
Zurück zum Zitat Peck LW, Monsen ER, Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nutr. 1996;64:210–4.PubMed Peck LW, Monsen ER, Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in hemodialysis patients. Am J Clin Nutr. 1996;64:210–4.PubMed
11.
Zurück zum Zitat Peck LW. Essential fatty acid deficiency in renal failure: can supplements really help? J Am Diet Assoc. 1997;97(10 Suppl 2):S150–3.CrossRefPubMed Peck LW. Essential fatty acid deficiency in renal failure: can supplements really help? J Am Diet Assoc. 1997;97(10 Suppl 2):S150–3.CrossRefPubMed
12.
Zurück zum Zitat Yasuhiko T, Yasuyuki S, Nobuyaki S, Ronald J, et al. Gas chromatography\mass spectrometry analysis of very long chain fatty acids. 2003;27:281–7. Yasuhiko T, Yasuyuki S, Nobuyaki S, Ronald J, et al. Gas chromatography\mass spectrometry analysis of very long chain fatty acids. 2003;27:281–7.
13.
Zurück zum Zitat Beddhu S, Pappas LM, Ramkumar N, Samore MH. Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol. 2004;15:733–42.CrossRefPubMed Beddhu S, Pappas LM, Ramkumar N, Samore MH. Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol. 2004;15:733–42.CrossRefPubMed
14.
Zurück zum Zitat Lauretani F, Maggio M, Pizzarelli F, Michelassi S, Ruggiero C, Ceda GP, et al. Omega-3 and renal function in older adults. Curr Pharm Des. 2009;15(36):4149–56.CrossRefPubMed Lauretani F, Maggio M, Pizzarelli F, Michelassi S, Ruggiero C, Ceda GP, et al. Omega-3 and renal function in older adults. Curr Pharm Des. 2009;15(36):4149–56.CrossRefPubMed
15.
Zurück zum Zitat Sharma BK, Jindal SK, Rana DS. Absence of hypedipidemia in patients of chronic renal failure in Chandigarh. Indian J Med Res. 1980;72:461–4.PubMed Sharma BK, Jindal SK, Rana DS. Absence of hypedipidemia in patients of chronic renal failure in Chandigarh. Indian J Med Res. 1980;72:461–4.PubMed
16.
Zurück zum Zitat de Gómez Dumm INT, Giammona AM, Touceda LA, Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina. 2001;61:142–6.PubMed de Gómez Dumm INT, Giammona AM, Touceda LA, Raimondi C. Lipid abnormalities in chronic renal failure patients undergoing hemodialysis. Medicina. 2001;61:142–6.PubMed
17.
Zurück zum Zitat Gupta DK. Hyperlipidemia in patients of chronic renal failure. Bombay Hosp J. 1991;33:45–50. Gupta DK. Hyperlipidemia in patients of chronic renal failure. Bombay Hosp J. 1991;33:45–50.
18.
Zurück zum Zitat Das BS, Mishra SK, Rao DVP. Serum lipids in chronic renal failure. J Assoc Phys India. 1984;32:1019–21. Das BS, Mishra SK, Rao DVP. Serum lipids in chronic renal failure. J Assoc Phys India. 1984;32:1019–21.
19.
Zurück zum Zitat Bagdade J, Casaretto A. Effect of chronic uremia, haemodialysis and renal transplantation on plasma lipids and lipoproteins. J Clin Invest. 1976;87:37–41. Bagdade J, Casaretto A. Effect of chronic uremia, haemodialysis and renal transplantation on plasma lipids and lipoproteins. J Clin Invest. 1976;87:37–41.
20.
Zurück zum Zitat Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in’uremia. Kidney Int. 1981;19:625–37.CrossRefPubMed Chan MK, Varghese Z, Moorhead JF. Lipid abnormalities in’uremia. Kidney Int. 1981;19:625–37.CrossRefPubMed
21.
Zurück zum Zitat Ibels LS, Simons LA, King JD. Plasma post heparin lipolytic activity and triglyceride clearance in uremic haemodialysis patients and renal allograft recipients. J Lab Clin Med. 1976;87:648–58.PubMed Ibels LS, Simons LA, King JD. Plasma post heparin lipolytic activity and triglyceride clearance in uremic haemodialysis patients and renal allograft recipients. J Lab Clin Med. 1976;87:648–58.PubMed
22.
Zurück zum Zitat House AA, Wells GA, Donnelly JG, Nadler SP, Hebert PC. Randomized trial of high-flux vs. low-flux hemodialysis: effects on homocysteine and lipids. Nephrol Dial Transplant. 2000;15:1029–34.CrossRefPubMed House AA, Wells GA, Donnelly JG, Nadler SP, Hebert PC. Randomized trial of high-flux vs. low-flux hemodialysis: effects on homocysteine and lipids. Nephrol Dial Transplant. 2000;15:1029–34.CrossRefPubMed
23.
Zurück zum Zitat Bloch K, Vance D. Control mechanisms in the synthesis of saturated fatty acids. Annu Rev Biochem. 1977;46:283–8.CrossRef Bloch K, Vance D. Control mechanisms in the synthesis of saturated fatty acids. Annu Rev Biochem. 1977;46:283–8.CrossRef
24.
Zurück zum Zitat Varga Z, Karpati I, Paragh G, Buris L, Kakuk G. Relative abundance of some free fatty acids in plasma of uremic patients: Relationship between fatty acids, lipid parameters, and diseases. Nephron. 1997;77:417–21.CrossRefPubMed Varga Z, Karpati I, Paragh G, Buris L, Kakuk G. Relative abundance of some free fatty acids in plasma of uremic patients: Relationship between fatty acids, lipid parameters, and diseases. Nephron. 1997;77:417–21.CrossRefPubMed
25.
Zurück zum Zitat Stocks J, Dormandy T. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol. 1971;20:95–111.CrossRefPubMed Stocks J, Dormandy T. The autoxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol. 1971;20:95–111.CrossRefPubMed
26.
Zurück zum Zitat Sasagawa T, Suzuki K, Shiota T, Kondo T, Okita M. The significance of plasma lysophospholipid in patients with renal failure on hemodialysis. J Nutr Sci Vitaminol (Tokyo). 1998;44:809–18. Sasagawa T, Suzuki K, Shiota T, Kondo T, Okita M. The significance of plasma lysophospholipid in patients with renal failure on hemodialysis. J Nutr Sci Vitaminol (Tokyo). 1998;44:809–18.
27.
Zurück zum Zitat Yawata Y, Jacob HS. Abnormal red cell metabolism in patients with chronic uremia: nature of the defect and its persistence despite adequate haemodialysis. Blood. 1975;45:231–9.PubMed Yawata Y, Jacob HS. Abnormal red cell metabolism in patients with chronic uremia: nature of the defect and its persistence despite adequate haemodialysis. Blood. 1975;45:231–9.PubMed
28.
Zurück zum Zitat Varga Z, Kárpáti I, Paragh G, Buris L, Kakuk G. Relative abundance of some free fatty acids in plasma of uremic patients: relationship between fatty acids, lipid parameters, and diseases. Nephron. 1997;77(4):417–21.CrossRefPubMed Varga Z, Kárpáti I, Paragh G, Buris L, Kakuk G. Relative abundance of some free fatty acids in plasma of uremic patients: relationship between fatty acids, lipid parameters, and diseases. Nephron. 1997;77(4):417–21.CrossRefPubMed
29.
Zurück zum Zitat Dasgupta A, Kenny MA, Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: possible deficiency of essential fatty acids. Clin Physiol Biochem. 1990;8(5):238–43.PubMed Dasgupta A, Kenny MA, Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: possible deficiency of essential fatty acids. Clin Physiol Biochem. 1990;8(5):238–43.PubMed
30.
Zurück zum Zitat Sinzinger M, Leitner C. Eicosanoids of platelet and vascular wall in chronic renal insufficiency. Am J Nephrol. 1987;7:211–30.CrossRef Sinzinger M, Leitner C. Eicosanoids of platelet and vascular wall in chronic renal insufficiency. Am J Nephrol. 1987;7:211–30.CrossRef
31.
Zurück zum Zitat de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean a-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–9.CrossRefPubMed de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean a-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454–9.CrossRefPubMed
32.
Zurück zum Zitat Grimsgaard S, Bonaa KH, Bjerve KS. Fatty acid chain length and degree of unsaturation are inversely associated with serum triglycerides. Lipids. 2000;35:1185–93.CrossRefPubMed Grimsgaard S, Bonaa KH, Bjerve KS. Fatty acid chain length and degree of unsaturation are inversely associated with serum triglycerides. Lipids. 2000;35:1185–93.CrossRefPubMed
33.
Zurück zum Zitat An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, et al. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Renal Nutr. 2009;19(4):267–74.CrossRef An WS, Kim SE, Kim KH, Lee S, Park Y, Kim HJ, et al. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Renal Nutr. 2009;19(4):267–74.CrossRef
34.
Zurück zum Zitat Katerina H, Maria H, Anatoli P, Vassilios M, Theodouli P, Victor A, et al. Plasma fatty acids in asthmatic children of Northern Greece. Arch Med Sci. 2009;5(1):51–6. Katerina H, Maria H, Anatoli P, Vassilios M, Theodouli P, Victor A, et al. Plasma fatty acids in asthmatic children of Northern Greece. Arch Med Sci. 2009;5(1):51–6.
35.
Zurück zum Zitat Khan MS, Chandanpreet S, Kewal K, Sanjay D, Ram KJ, Atu Sl. Malnutrition, Anthropometric, and biochemical abnormalities in patients with diabetic nephropathy. Journal of Renal Nut. 2009;19(4):275–82.CrossRef Khan MS, Chandanpreet S, Kewal K, Sanjay D, Ram KJ, Atu Sl. Malnutrition, Anthropometric, and biochemical abnormalities in patients with diabetic nephropathy. Journal of Renal Nut. 2009;19(4):275–82.CrossRef
36.
Zurück zum Zitat Perunicic-Pekovic G, Rasic Z, Ristic V, Pljesa S, Lambic LJ, Djurkovic V. Interactions between nutritional parameters and polyunsaturated fatty acids (PUFAs) profiles in plasma phospholipids in hemodialysis patients. Cardionephrology, Editoriale Bios, Cosenza. 2004;8:333–5. Perunicic-Pekovic G, Rasic Z, Ristic V, Pljesa S, Lambic LJ, Djurkovic V. Interactions between nutritional parameters and polyunsaturated fatty acids (PUFAs) profiles in plasma phospholipids in hemodialysis patients. Cardionephrology, Editoriale Bios, Cosenza. 2004;8:333–5.
37.
Zurück zum Zitat Ristic V, Tepsic V, Ristic-Medic D, et al. Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialyzed patients. Ren Fail. 2006;28:211–6.CrossRefPubMed Ristic V, Tepsic V, Ristic-Medic D, et al. Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialyzed patients. Ren Fail. 2006;28:211–6.CrossRefPubMed
38.
Zurück zum Zitat Perunicic-Pekovic GB, Rasic ZR, Pljesa SI, Sobajic SS, Djuricic I, Maletic R, et al. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology. 2007;12:331–6.CrossRefPubMed Perunicic-Pekovic GB, Rasic ZR, Pljesa SI, Sobajic SS, Djuricic I, Maletic R, et al. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology. 2007;12:331–6.CrossRefPubMed
39.
Zurück zum Zitat Vernaglione L, Cristofano C, Chimienti S. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study. J Nephrol. 2008;21(1):99–105.PubMed Vernaglione L, Cristofano C, Chimienti S. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study. J Nephrol. 2008;21(1):99–105.PubMed
40.
Zurück zum Zitat Gennaro C, Luigi F, Attilio Di B, Russo PE, Marinelli G, Francesco P, et al. Dilated cardiomyopathy in dialysis patients—beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol. 2001;37:407–11.CrossRef Gennaro C, Luigi F, Attilio Di B, Russo PE, Marinelli G, Francesco P, et al. Dilated cardiomyopathy in dialysis patients—beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol. 2001;37:407–11.CrossRef
41.
Zurück zum Zitat Meritt H. Raitt are n-3 polyunsaturated fatty acids antiarrhythmic in the absence of ischemia? In: Nodari S, et al., editors. The role of n-3 PUFAs in preventing the arrhythmic risk in patientswith idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther. 2009;23:1–3. Meritt H. Raitt are n-3 polyunsaturated fatty acids antiarrhythmic in the absence of ischemia? In: Nodari S, et al., editors. The role of n-3 PUFAs in preventing the arrhythmic risk in patientswith idiopathic dilated cardiomyopathy. Cardiovasc Drugs Ther. 2009;23:1–3.
42.
Zurück zum Zitat Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003;167:23742.CrossRef Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis. 2003;167:23742.CrossRef
43.
Zurück zum Zitat Bemelmans WJ, Lefrandt JD, Feskens EJ, et al. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr. 2004;58:10839.CrossRef Bemelmans WJ, Lefrandt JD, Feskens EJ, et al. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr. 2004;58:10839.CrossRef
44.
Zurück zum Zitat Trebble T, Arden NK, Stroud MA, et al. Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr. 2003;90:40512.CrossRef Trebble T, Arden NK, Stroud MA, et al. Inhibition of tumour necrosis factor-alpha and interleukin 6 production by mononuclear cells following dietary fish-oil supplementation in healthy men and response to antioxidant co-supplementation. Br J Nutr. 2003;90:40512.CrossRef
Metadaten
Titel
Serum Lipid Profile and Plasma Fatty Acids Levels in Hemodialysis Pediatric Patients-Possible Deficiency of Essential Fatty Acids
verfasst von
Manal Fuad Elshamaa
Samar Mohamed Sabry
Eman Ahmed Elghoroury
Gamila Soliman El-Saaid
Dina Kandil
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Kidney / Ausgabe 6/2010
Print ISSN: 0940-7936
Elektronische ISSN: 1865-5068
DOI
https://doi.org/10.1007/s00596-010-0188-9

Weitere Artikel der Ausgabe 6/2010

Kidney 6/2010 Zur Ausgabe

Nephrology in Brief

Nephrology in Brief 19:6

Literature Survey

E. Transplantation

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.